Keyphrases
Proton
100%
Resection
100%
Pneumonia
100%
Esophageal Cancer
100%
Neoadjuvant Chemoradiotherapy (nCRT)
100%
Proton Radiotherapy
81%
Lung
45%
Radiotherapy
45%
Radiotherapy Techniques
45%
DVH Parameters
36%
Mean Dose
27%
Radiation Dose
18%
Logistic Regression Analysis
18%
Confounding
18%
Current Analysis
18%
Baseline Characteristics
18%
Surgical Resection
18%
Surgical Variables
18%
Complete Case
18%
Proton Therapy
9%
Patient Selection
9%
Model-based Approach
9%
Neuroendocrine Carcinoma
9%
Relevant Parameters
9%
High Dose
9%
Multivariate Model
9%
Conventional Treatment
9%
Dose Distribution
9%
Patient Characteristics
9%
Multivariable
9%
Adverse Events
9%
Logistic Regression Model
9%
Treatment Strategy
9%
Dose Reduction
9%
Patient Tumor
9%
Treatment Characteristics
9%
Chi-square Test
9%
Combined Modality Therapy
9%
Minimally Invasive
9%
Tumor Characteristics
9%
Patient Treatment
9%
Healthy Tissue
9%
Anastomosis
9%
Complication Risk
9%
Association Analysis
9%
Serious Complications
9%
Multicollinearity
9%
Univariable Analysis
9%
Several Variables
9%
Timing of Surgery
9%
Clinical Knowledge
9%
Common Terminology Criteria for Adverse Events (CTCAE)
9%
Mann
9%
Potential Interaction
9%
Surgery Treatment
9%
Thoracic Radiotherapy
9%
Data Registry
9%
3-Component
9%
PCA Analysis
9%
Surgical Access
9%
U-test
9%
Postoperative Pneumonia
9%
Backward Selection
9%
Missing Variables
9%
Medicine and Dentistry
Surgery
100%
Radiation Therapy
100%
Esophageal Cancer
100%
Chemoradiotherapy
100%
Proton Therapy
90%
Chronic Obstructive Pulmonary Disease
45%
Logistic Regression Analysis
27%
Low Drug Dose
18%
Neoplasm
9%
Randomized Controlled Trial
9%
Adverse Event
9%
Drug Megadose
9%
Drug Dose Reduction
9%
Chi Square Test
9%
Surgical Anastomosis
9%
Neuroendocrine Carcinoma
9%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Esophagus Cancer
100%
Chemoradiation Therapy
100%
Randomized Controlled Trial
20%
Neoplasm
20%
Adverse Event
20%
Neuroendocrine Carcinoma
20%
Biochemistry, Genetics and Molecular Biology
Low Drug Dose
100%
Randomized Controlled Trial
50%
Drug Megadose
50%
Radiation Dose Distribution
50%
Chi-Square Testing
50%
Drug Dose Reduction
50%
Immunology and Microbiology
Low Drug Dose
100%
Drug Megadose
50%
Drug Dose Reduction
50%
Radiation Dose Distribution
50%